In-flight impairment and incapacitation are defined as states wherein the pilot's ability to effectively control the aircraft is adversely affected. They are of special concern in general aviation given there may be no second pilot to take over the controls. The purpose of the present study was to examine the characteristics of fatal general aviation accidents associated with impairment and incapacitation. A comprehensive review of 2,696 fatal general aviation accidents from 1990–1998 using database records maintained by the NTSB and FAA yielded 216 accidents (8.01%) that had some form of impairment/incapacitation or physiological causes mentioned in the accident report. Impairment due to drugs ( n = 88, 40.7%) and alcohol ( n = 68, 31.5%) were the most common causes. Cardiovascular causes were cited in 12.03% (n = 26) of the cases. Significant relationships were observed between age and impairment/incapacitation due to alcohol, drugs, and cardiovascular causes. Some disparities were observed between the prevalence of alcohol in toxicology samples and alcohol impairment being cited in the accident report as a contributory factor. The analysis provides some insight into the possible causes of pilot impairment and incapacitation in general aviation. Education and risk management training may serve as effective interventions.
This study provides insights into the nature of spinal disabilities in civil and military aviation. Ejection and aircraft accidents remain the leading cause of vertebral fractures. Disc degenerative disease is a cause of concern. Physical conditioning and regular physical exercise may possibly minimize spinal disabilities in susceptible aircrew.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.